IMRX Immuneering Corporation - Class A Common Stock
$5.22
价格 · 八月 19, 2026
截至...的财报数据 八月 5, 2026
52周区间
$3–$10
29% of range
分析师评级
BUY
13 analysts
目标价
$18
+250% upside
P/E (TTM)
-5.2
ROE
-45.3%
净利润率
—
IMRX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$5.22
市值
—
P/E (TTM)
-5.2
每股收益 (TTM)
$-1.27
营收 (TTM)
$0
股息收益率
—
ROE
-45.3%
负债/权益
—
52周区间
$3 – $10
IMRX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2020-12-31
→
2023-12-31
EPS
$-1.27
2020-12-31
→
2025-12-31
自由现金流
$-45M
2021-12-31
→
2025-12-31
利润率
—
2021-12-31
→
2022-12-31
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
IMRX
同行中位数
P/E (TTM)
-5.2
4.8
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
IMRX
同行中位数
ROA
-39.4%
-40.4%
ROE
-45.3%
-52.2%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
IMRX
同行中位数
Current Ratio (流动比率)
17.5
6.5
Quick Ratio (速动比率)
12.8
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
IMRX
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
IMRX
同行中位数
IMRX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
13 位分析师
- 强烈买入 4 30.8%
- 买入 8 61.5%
- 持有 1 7.7%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
8 位分析师 · 2026-08-17
中位数
$17.50
← 低于所有目标
$5.22
最低
$12.00
最高
$30.00
中位数目标
$17.50
+235.2%
平均目标
$18.25
+249.6%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.06%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.27 | $-0.27 | 0.00% |
| 2026年3月31日 | $-0.21 | $-0.26 | 0.05% |
| 2025年12月31日 | $-0.18 | $-0.32 | 0.14% |
| 2025年9月30日 | $-0.38 | $-0.40 | 0.02% |
| 2025年6月30日 | $-0.40 | $-0.42 | 0.02% |
| 2025年3月31日 | $-0.42 | $-0.54 | 0.12% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IMRX | — | -5.2 | — | — | -45.3% | — |
| DMAC | $428M | — | — | — | -78.7% | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
| ZNTL | $93M | -0.7 | — | — | -49.5% | — |
| SABS | — | — | — | — | — | — |
| TLSI | — | — | — | — | — | — |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | — |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | — |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $317.0K | $2M | $2M | |
| Cost of Revenue | · | · | $0 | $158.1K | $1M | $1M | |
| Gross Profit | · | · | $0 | $158.8K | $926.9K | $1M | |
| R&D Expense | $42M | $48M | $42M | $36M | $27M | $15M | |
| SG&A Expense | $17M | $16M | $17M | $16M | $8M | $3M | |
| Operating Expenses | $59M | $64M | $58M | $52M | $35M | $18M | |
| Operating Income | $-59M | $-64M | $-58M | $-52M | $-34M | $-17M | |
| Interest Income | $3M | $3M | $4M | $1M | $169.9K | $42.7K | |
| Other Non-op | $311.7K | $441.5K | $1M | $216.8K | $-127.1K | · | |
| Pretax Income | · | · | · | $-51M | $-34M | $-17M | |
| Income Tax | $0 | · | · | · | $-307.5K | · | |
| Net Income | $-56M | $-61M | $-53M | $-51M | $-34M | $-17M | |
| EPS (Basic) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | |
| EPS (Diluted) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 | $-3.44 | |
| Shares (Basic) | 44,011,830 | 29,981,565 | 28,416,558 | 26,386,864 | 13,612,677 | 4,950,129 | |
| Shares (Diluted) | 44,011,830 | 29,981,565 | 28,416,558 | 26,386,864 | 13,612,677 | 4,950,129 | |
| EBITDA | $-59M | $-64M | $-58M | $-52M | $-34M | · |
资产负债表 22
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $129M | $36M | $59M | $73M | $75M | $37M | |
| Short-term Investments | · | · | · | $33M | $74M | · | |
| Receivables | · | · | $0 | $12.4K | $246.0K | $500.1K | |
| Prepaid Expense | $3M | $3M | $3M | $3M | $3M | $141.0K | |
| Current Assets | $176M | $40M | $89M | $109M | $152M | $38M | |
| PP&E (Net) | $938.5K | $1M | $1M | $1M | $807.2K | $64.4K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $981.4K | $193.1K | |
| Accum. Depreciation | $1M | $1M | $728.3K | $418.3K | $174.2K | $128.8K | |
| Goodwill | $7M | $7M | $7M | $7M | $7M | · | |
| Intangibles | $321.1K | $350.4K | $379.7K | $408.9K | $439.0K | · | |
| Other Non-current Assets | $283.6K | $1M | $1M | $743.7K | $102.1K | $14.3K | |
| Total Assets | $232M | $53M | $103M | $122M | $167M | $38M | |
| Accounts Payable | $2M | $2M | $2M | $3M | $1M | $1M | |
| Accrued Liabilities | $8M | $5M | $5M | $5M | $4M | $699.0K | |
| Current Liabilities | $10M | $8M | $8M | $8M | $6M | $2M | |
| Capital Leases | $3M | $4M | $4M | $4M | $5M | $544.8K | |
| Total Liabilities | $14M | $11M | $12M | $13M | $11M | $3M | |
| Paid-in Capital | $499M | $266M | $254M | $220M | $215M | $3M | |
| Retained Earnings | $-280M | $-224M | $-163M | $-110M | $-59M | $-26M | |
| AOCI | $81.3K | $0 | $-778 | $-30.1K | $-49.0K | · | |
| Stockholders' Equity | $218M | $41M | $91M | $110M | $156M | $-22M | |
| Liabilities + Equity | $232M | $53M | $103M | $122M | $167M | $38M |
现金流 13
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $324.5K | $355.8K | $322.8K | · | · | · | |
| Stock-based Comp | $6M | $7M | $6M | $4M | $2M | $1M | |
| Deferred Tax | · | · | · | · | $-307.5K | · | |
| Amort. of Intangibles | $29.3K | $29.3K | $29.3K | $30.1K | · | · | |
| Other Non-cash | $4M | $-820.1K | · | · | · | · | |
| Operating Cash Flow | $-45M | $-55M | $-49M | $-44M | $-31M | $-15M | |
| CapEx | $142.2K | $84.9K | $342.7K | $742.5K | $60.8K | $53.4K | |
| Investing Cash Flow | $-89M | $26M | $7M | $42M | $-76M | $-53.4K | |
| Stock Issued | · | · | $28M | $0 | $120M | · | |
| Net Stock Activity | · | · | $28M | · | $120M | · | |
| Financing Cash Flow | $227M | $5M | $28M | $19.0K | $144M | $38M | |
| Net Change in Cash | $93M | $-23M | $-13M | $-2M | $38M | $23M | |
| Free Cash Flow | $-45M | $-55M | $-49M | $-45M | $-31M | · |
盈利能力 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 50.1% | 44.6% | · | |
| Operating Margin | · | · | · | -16325.8% | -1629.2% | · | |
| Net Margin | · | · | · | -15937.3% | -1612.3% | · | |
| Pretax Margin | · | · | · | -15937.3% | -1627.1% | · | |
| EBITDA Margin | · | · | · | -16325.8% | -1629.2% | · | |
| ROA | -39.4% | -78.6% | -47.5% | -34.9% | -32.7% | · | |
| ROE | -45.3% | -123.2% | -55.0% | -43.6% | -21.3% | · | |
| ROIC | · | · | · | · | -21.5% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 17.5 | 5.3 | 11.4 | 13.5 | 27.0 | · | |
| Quick Ratio | 12.8 | 4.8 | 7.6 | 13.1 | 26.5 | · |
效率 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | 0.0 | 2.5 | 5.6 | · |
增长率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -84.8% | -10.0% | · |
估值 (TTM) 4
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $38.4K | $38.4K | $0 | $317.0K | $2M | · | |
| Net Income TTM | $-56M | $-61M | $-53M | $-51M | $-34M | · | |
| P/E | -5.2 | -1.1 | -3.9 | -2.5 | -6.6 | · | |
| Earnings Yield | -19.3% | -92.7% | -25.6% | -39.4% | -15.2% | · |
损益表 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $455 | $38.4K | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $19.3K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $455 | $19.0K | |
| R&D Expense | $14M | $11M | $9M | $11M | $10M | $11M | $15M | $11M | $11M | $11M | $12M | $10M | $9M | $10M | $10M | $9M | |
| SG&A Expense | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Operating Expenses | $19M | $15M | $14M | $15M | $15M | $15M | $19M | $15M | $15M | $15M | $16M | $14M | $14M | $15M | $14M | $13M | |
| Operating Income | $-19M | $-15M | $-14M | $-15M | $-15M | $-15M | $-19M | $-15M | $-15M | $-15M | $-16M | $-14M | $-14M | $-15M | $-14M | $-13M | |
| Interest Income | $1M | $1M | $2M | $415.8K | $324.0K | $438.5K | $415.2K | $547.1K | $826.1K | $804.9K | $754.1K | $855.5K | $1M | $831.3K | $516.2K | $223.0K | |
| Other Non-op | $647.2K | $513.7K | $311.7K | $0 | $0 | $0 | $91.4K | $129.3K | $7.7K | $213.0K | $464.4K | $475.6K | $150.2K | $244.1K | $223.3K | $120.8K | |
| Net Income | $-17M | $-13M | $-12M | $-15M | $-14M | $-15M | $-18M | $-15M | $-14M | $-14M | $-15M | $-13M | $-12M | $-14M | $-13M | $-13M | |
| EPS (Basic) | $-0.27 | $-0.21 | $-0.07 | $-0.38 | $-0.40 | $-0.42 | $-0.59 | $-0.49 | $-0.47 | $-0.49 | $-0.51 | $-0.43 | $-0.43 | $-0.51 | $-0.49 | $-0.49 | |
| EPS (Diluted) | $-0.27 | $-0.21 | $-0.07 | $-0.38 | $-0.40 | $-0.42 | $-0.59 | $-0.49 | $-0.47 | $-0.49 | $-0.51 | $-0.43 | $-0.43 | $-0.51 | $-0.49 | $-0.49 | |
| Shares (Basic) | 64,697,219 | 64,658,809 | -67,173,795 | 39,670,095 | 35,985,878 | 35,529,652 | -58,884,030 | 29,841,883 | 29,653,355 | 29,370,357 | -55,939,417 | 29,266,309 | 28,647,450 | 26,442,216 | -52,753,049 | 26,394,490 | |
| Shares (Diluted) | 64,697,219 | 64,658,809 | -67,173,795 | 39,670,095 | 35,985,878 | 35,529,652 | -58,884,030 | 29,841,883 | 29,653,355 | 29,370,357 | -55,939,417 | 29,266,309 | 28,647,450 | 26,442,216 | -52,753,049 | 26,394,490 | |
| EBITDA | $-19M | $-15M | · | $-15M | $-15M | $-15M | · | $-15M | $-15M | $-15M | · | $-14M | $-13M | $-15M | · | $-13M |
资产负债表 22
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $41M | $47M | $129M | $228M | $26M | $36M | $36M | $45M | $60M | $66M | $59M | $68M | $104M | $77M | $73M | $76M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $1.0K | $12.4K | $70.2K | |
| Prepaid Expense | $8M | $5M | $3M | $2M | $1M | $2M | $3M | $5M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Current Assets | $158M | $161M | $176M | $229M | $28M | $38M | $40M | $55M | $64M | $74M | $89M | $101M | $112M | $94M | $109M | $120M | |
| PP&E (Net) | $879.9K | $937.0K | $938.5K | $892.6K | $964.1K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $997.0K | $909.0K | $818.5K | $728.3K | $648.0K | $569.7K | $492.9K | $418.3K | $344.6K | |
| Goodwill | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Intangibles | $306.5K | $313.8K | $321.1K | $328.5K | $335.8K | $343.1K | $350.4K | $357.7K | $365.0K | $372.4K | $379.7K | $387.0K | $394.3K | $401.6K | $408.9K | $416.3K | |
| Other Non-current Assets | $278.1K | $278.1K | $283.6K | $631.3K | $841.7K | $810.9K | $1M | $1M | $1M | $1M | $1M | $743.7K | $743.7K | $743.7K | $743.7K | $737.3K | |
| Total Assets | $202M | $215M | $232M | $241M | $40M | $51M | $53M | $69M | $77M | $88M | $103M | $114M | $125M | $108M | $122M | $134M | |
| Accounts Payable | $3M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | |
| Accrued Liabilities | $4M | $3M | $8M | $7M | $5M | $3M | $5M | $5M | $4M | $3M | $5M | $3M | $2M | $2M | $5M | $5M | |
| Current Liabilities | $8M | $5M | $10M | $10M | $7M | $5M | $8M | $7M | $7M | $5M | $8M | $6M | $5M | $6M | $8M | $7M | |
| Capital Leases | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | |
| Total Liabilities | $11M | $8M | $14M | $13M | $11M | $9M | $11M | $11M | $11M | $9M | $12M | $10M | $10M | $10M | $13M | $12M | |
| Paid-in Capital | $502M | $500M | $499M | $497M | $283M | $281M | $266M | $264M | $258M | $256M | $254M | $252M | $251M | $221M | $220M | $219M | |
| Retained Earnings | $-311M | $-294M | $-280M | $-269M | $-254M | $-239M | $-224M | $-206M | $-192M | $-178M | $-163M | $-148M | $-136M | $-123M | $-110M | $-97M | |
| AOCI | $-406.2K | $-241.0K | $81.3K | · | · | · | $0 | $7.8K | $0 | $-1.1K | $-778 | $5.6K | $-2.2K | $506 | $-30.1K | $-142.5K | |
| Stockholders' Equity | $191M | $207M | $218M | $228M | $29M | $42M | $41M | $58M | $66M | $79M | $91M | $104M | $115M | $98M | $110M | $122M | |
| Liabilities + Equity | $202M | $215M | $232M | $241M | $40M | $51M | $53M | $69M | $77M | $88M | $103M | $114M | $125M | $108M | $122M | $134M |
现金流 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84.5K | $81.4K | $75.9K | $78.8K | $84.5K | $85.3K | $86.1K | $88.9K | $90.5K | $90.2K | $89.8K | $78.3K | $78.2K | $76.5K | · | $68.1K | |
| Stock-based Comp | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | |
| Amort. of Intangibles | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | $7.3K | |
| Other Non-cash | · | $-7M | · | · | · | $-812.0K | · | · | · | $-3M | · | · | · | · | · | · | |
| Operating Cash Flow | $-17M | $-18M | $-10M | $-12M | $-9M | $-14M | $-15M | $-13M | $-12M | $-15M | $-12M | $-12M | $-11M | $-14M | $-12M | $-11M | |
| CapEx | $27.4K | $79.9K | $123.9K | $7.3K | $2.1K | $8.9K | $9.4K | $5.3K | $32.8K | $37.5K | $170.9K | $57.1K | $86.7K | $28.0K | $69.3K | $393.1K | |
| Investing Cash Flow | $10M | $-63M | $-89M | $-7.3K | $-2.1K | $-8.9K | $5M | $-5M | $5M | $21M | $3M | $-24M | $9M | $19M | $8M | $-880.1K | |
| Stock Issued | · | · | · | · | $0 | $14M | · | · | $0 | $0 | · | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $14M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24.6K | $180.8K | $-357.5K | $213M | $-62.0K | $14M | $-41.0K | $4M | $0 | $979.9K | $7.8K | $21.4K | $28M | $239.4K | $-184.7K | $-17.2K | |
| Net Change in Cash | $-6M | $-81M | $-99M | $201M | $-10M | $-279.0K | $-9M | $-15M | $-7M | $7M | $-9M | $-36M | $27M | $5M | $-4M | $-12M | |
| Free Cash Flow | · | $-19M | · | · | · | $-14M | · | · | · | $-16M | · | · | · | $-14M | · | · |
盈利能力 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 49.6% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -34362.0% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -33466.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -34362.0% | |
| ROA | -14.3% | -10.1% | · | -9.7% | -24.6% | -21.7% | · | -16.0% | -13.9% | -14.6% | · | -10.2% | -9.1% | -10.5% | · | -8.6% | |
| ROE | -15.7% | -10.8% | · | -10.5% | -30.3% | -25.0% | · | -18.1% | -15.5% | -16.2% | · | -11.2% | -9.8% | -11.2% | · | -9.2% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.5 | 32.4 | · | 24.0 | 3.7 | 7.5 | · | 8.0 | 9.4 | 14.4 | · | 17.9 | 20.4 | 17.1 | · | 16.5 | |
| Quick Ratio | 5.1 | 9.5 | · | 23.8 | 3.5 | 7.0 | · | 6.5 | 8.8 | 12.8 | · | 12.1 | 19.0 | 14.0 | · | 16.2 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.1 |
估值 (TTM) 4
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $38.4K | $38.4K | · | $38.4K | $38.4K | $38.4K | · | $38.4K | $38.4K | $38.4K | · | $38.4K | $132.8K | $316.5K | · | $798.6K | |
| Net Income TTM | $-60M | $-58M | · | $-59M | $-58M | $-58M | · | $-56M | $-53M | $-53M | · | $-51M | $-50M | $-51M | · | $-46M | |
| P/E | -4.0 | -3.7 | · | -4.1 | -1.9 | -0.8 | · | -1.3 | -0.7 | -1.6 | · | -4.1 | -5.4 | -5.0 | · | -7.6 | |
| Earnings Yield | -25.2% | -26.8% | · | -24.1% | -52.8% | -123.0% | · | -75.5% | -142.2% | -64.4% | · | -24.2% | -18.4% | -19.9% | · | -13.2% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | — | — | $0 | $317.0K | $2M |
| 毛利率 % | — | — | — | 50.1% | 44.6% |
| 营业利润率 % | — | — | — | -16325.8% | -1629.2% |
| 净收入 | $-56M | $-61M | $-53M | $-51M | $-34M |
| 稀释后每股收益 (EPS) | $-1.27 | $-2.04 | $-1.88 | $-1.91 | $-2.46 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 17.5 | 5.3 | 11.4 | 13.5 | 27.0 |
| 速动比率 | 12.8 | 4.8 | 7.6 | 13.1 | 26.5 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-45M | $-55M | $-49M | $-45M | $-31M |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 121 家申报者 · $124.8M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 37 (+8 与上一季度对比) | 19 (+2 与上一季度对比) | 33 (+3 与上一季度对比) | 27 (+3 与上一季度对比) | +2.7M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
公司内部人士 12 位内幕人士 · 6 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Benjamin J. Zeskind | PRESIDENT AND CEO | 2026年6月23日 P | 2315252 | 1 | 0 | $10944 |
| Andrew Gengos | Chief Financial Officer | 2026年7月16日 A | — | 0 | 0 | $0 |
| Biren Amin | CFO, Treasurer | 2021年8月3日 C | 6898 | 0 | 0 | $0 |
| Brett Matthew Hall | CHIEF SCIENTIFIC OFFICER | 2026年6月15日 P | 382531 | 1 | 0 | $25045 |
| Scott Barrett | Chief Medical Officer | 2021年8月3日 C | 6663 | 0 | 0 | $0 |
| Michael Bookman | General Counsel and Secretary | 2021年8月3日 P | 1402 | 0 | 0 | $0 |
| Peter Feinberg | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Laurie Keating | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Diana Hausman | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Thomas J. Schall | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| CARPENTER ROBERT J | 董事 | 2026年6月11日 A | — | 0 | 0 | $0 |
| Ann E Berman | 董事 | 2021年8月3日 P | 3500 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 13 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| BIB · ProShares Trust | 0.02% | 2387 NS | 2026年5月31日 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.01% | 52296 NS | 2026年5月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 3598 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| IWN · iShares Trust | — | — | 2026年8月17日 | 每日 |
| IWM · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWC · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | — | — | 2026年7月20日 | 每日 |